William C Spanos Selected Research

Fibrosis (Cirrhosis)

1/2018

Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William C Spanos Research Topics

Disease

20	Neoplasms (Cancer) 10/2023 - 11/2009
12	Squamous Cell Carcinoma of Head and Neck 11/2023 - 11/2005
7	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 11/2009
2	Infections 10/2021 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 04/2016 - 04/2016
1	Thyroid Neoplasms (Thyroid Cancer) 04/2024
1	Chondrosarcoma 06/2023
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2023
1	Melanoma (Melanoma, Malignant) 11/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Surgical Wound 01/2021
1	Experimental Melanoma 01/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Neutropenia 07/2017
1	Lymphatic Metastasis 04/2016
1	Birth Weight (Birth Weights) 10/2009
1	Patent Ductus Arteriosus 10/2009
1	Paralysis (Palsy) 10/2009
1	Cytomegalovirus Infections (Inclusion Disease) 11/2005

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 11/2009
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2016
2	LigandsIBA 10/2023 - 11/2022
2	NeuropeptidesIBA 10/2023 - 11/2022
2	Oncogene Proteins (Oncogene Protein)IBA 10/2021 - 11/2019
2	CarcinogensIBA 10/2021 - 01/2021
2	130-nm albumin-bound paclitaxelIBA 03/2021 - 01/2021
2	Cetuximab (Erbitux)FDA Link 03/2021 - 01/2021
2	pembrolizumabIBA 01/2020 - 01/2016
2	ChemokinesIBA 01/2020 - 11/2019
2	AntigensIBA 11/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 07/2013 - 02/2008
1	Analgesics (Analgesic Drugs)IBA 03/2024
1	Therapeutic UsesIBA 10/2023
1	CalciumIBA 10/2023
1	Substance PIBA 10/2023
1	Death Domain ReceptorsIBA 01/2023
1	UbiquitinIBA 01/2023
1	Ligases (Synthetase)IBA 01/2023
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Calcitonin Gene-Related PeptideIBA 11/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 05/2021
1	Panitumumab (Vectibix)FDA Link 05/2021
1	NivolumabIBA 01/2021
1	AlbuminsIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Albumin-Bound Paclitaxel FDA Link 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Immunomodulating AgentsIBA 01/2019
1	CTLA-4 AntigenIBA 01/2019
1	Propranolol (Inderal)FDA LinkGeneric 10/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2018
1	Superoxide DismutaseIBA 01/2018
1	Filgrastim (Neupogen)FDA Link 07/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	Sirolimus (Rapamycin)FDA Link 04/2016
1	Granzymes (Granzyme)IBA 07/2013
1	Interferon-gamma (Interferon, gamma)IBA 07/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	Viral DNAIBA 11/2005
1	Cidofovir (Vistide)FDA Link 11/2005

Therapy/Procedure

10	Therapeutics 04/2024 - 11/2009
4	Chemoradiotherapy 05/2022 - 01/2020
4	Radiotherapy 01/2020 - 11/2009
3	Drug Therapy (Chemotherapy) 01/2020 - 07/2013
2	Immunotherapy 01/2021 - 01/2020
1	Lasers (Laser) 06/2023
1	Induction Chemotherapy 03/2021
1	Neoadjuvant Therapy 01/2021
1	Immunomodulation 01/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2018
1	Ligation 10/2009
1	Surgical Instruments (Clip) 10/2009
1	Sutures (Suture) 10/2009